Emerging Technology and Best Practices Seminar Series

Nanotechnology in Medicine: From Diagnostics to Therapeutics

Back to agenda

Omid Farokhzad, M.D., Assistant Professor of Anesthesia, Harvard Medical School

BIO

Omid Farokhzad is Assistant Professor of Anesthesia at Harvard Medical School (HMS), and Director of the Laboratory of Nanomedicine and Biomaterials at Brigham and Women's Hospital (BWH). Dr. Farokhzad has pioneered the application of micro- and nanotechnologies to combinatorial development and screening of therapeutic and diagnostic multifunctional nanoparticles for a myriad of clinical applications, including oncology, cardiovascular, and immunological diseases. His work has been the subject of extensive written, TV and radio press coverage, including being featured on the cover of Popular Science and being named as Forbes top 5 nanotechnology breakthroughs of 2006. He was named among the Nano50 winners of 2007 by NASA Nanotech Briefs which awards the most innovative people and design ideas that will revolutionize nanotechnology in the near-term and beyond. He is an inventor of over 25 patent applications. Dr. Farokhzad co-founded BIND Biosciences with Professor Robert Langer in 2006 to develop and commercialize the first generation of therapeutic targeted nanoparticles. He received his M.D. and M.A. degrees from Boston University and completed his postgraduate clinical training in Anesthesiology and Pain medicine at BWH-HMS, and his post-doctoral research training in the Laboratory of Professor Robert Langer at MIT.